{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:49:16Z","timestamp":1789631356628,"version":"build-2803163510"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tokyo University of Pharmacy and Life Sciences"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Oral mucositis (OM) is a common side effect in patients with cancer receiving chemotherapy and radiotherapy; however, no salivary mediator is known to be associated with OM. We aimed to determine candidate salivary inflammatory mediators potentially associated with OM in patients with cancer. To this end, we compared the relationships between OM grade, oral mucosal dryness, and inflammatory mediators (Interleukin (IL)-1\u03b2, IL-6, IL-10, IL-12p70, tumor necrosis factor (TNF), prostaglandin E2, and vascular endothelial growth factor) in patients with cancer and in healthy volunteers (HV). We collected saliva samples from 18 patients with cancer according to the following schedule: 1) within 14 days of treatment initiation, 2) within 3 days of OM occurrence, 3) when OM was improved or got worsened, and 4) within 7 days after chemotherapy completion. The oral care support team determined the OM grade at each sample collection point based on CTCAE version 5.0. Salivary inflammatory mediator concentrations were detected using cytometric bead array or enzyme-linked immunoassay. We compared oral mucosal dryness in pre- and post-index patients with cancer to that in HV (n = 33) using an oral moisture-checking device. Fourteen of eighteen patients experienced OM (four, grade 3 OM; four, grade 2 OM; six, grade 1 OM). IL-6, IL-10, and TNF salivary concentrations were significantly increased in the post-index group compared to those in the pre-index group (<jats:italic>p<\/jats:italic> = 0.0002, <jats:italic>p<\/jats:italic> = 0.0364, and <jats:italic>p<\/jats:italic> = 0.0160, respectively). Additionally, salivary IL-6, IL-10, and TNF levels were significantly higher in the post-index group than in the HV group (<jats:italic>p<\/jats:italic> &lt; 0.0001, <jats:italic>p<\/jats:italic> &lt; 0.05, and <jats:italic>p<\/jats:italic> &lt; 0.05, respectively). Significant positive correlations were observed between OM grade and salivary IL-6, IL-10, and TNF levels (<jats:italic>p<\/jats:italic> = 0.0004, r = 0.4939; <jats:italic>p<\/jats:italic> = 0.0171, r = 0.3394; and <jats:italic>p<\/jats:italic> = 0007, r = 0.4662, respectively). Oral mucosal dryness was significantly higher in the HV than in the pre- and post-index groups (<jats:italic>p<\/jats:italic> &lt; 0.001). Our findings suggest that salivary IL-6, IL-10, and TNF levels may be used as biomarkers for OM occurrence and grade in patients with cancer. Furthermore, monitoring oral mucosal dryness and managing oral hygiene before cancer treatment is essential.<\/jats:p>","DOI":"10.1371\/journal.pone.0267092","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T17:34:41Z","timestamp":1651080881000},"page":"e0267092","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3802-0210","authenticated-orcid":true,"given":"Anna","family":"Kiyomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Usuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetoshi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"pone.0267092.ref001","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.3390\/ijerph18147418","article-title":"Efficacy of photobiomodulation in the treatment of cancer chemotherapy-induced oral mucositis: a meta-analysis with trial sequential analysis","volume":"18","author":"AHM Al-Rudayni","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"pone.0267092.ref002","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fphar.2017.00354","article-title":"New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury","volume":"8","author":"M Cinausero","year":"2017","journal-title":"Front Pharmacol"},{"key":"pone.0267092.ref003","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00277-015-2437-5","article-title":"A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation","volume":"94","author":"I Sakellari","year":"2015","journal-title":"Ann Hematol"},{"key":"pone.0267092.ref004","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","article-title":"Mucositis: the impact, biology and therapeutic opportunities of oral mucositis","volume":"45","author":"ST Sonis","year":"2009","journal-title":"Oral Oncol"},{"key":"pone.0267092.ref005","first-page":"81","article-title":"Salivary and serum concentrations of selected pro- and antiinflammatory cytokines in relation to oral lesions among children undergoing maintenance therapy of acute lymphoblastic leukemia","volume":"23","author":"PM Krzaczek","year":"2019","journal-title":"Contemp Oncol (Pozn)"},{"key":"pone.0267092.ref006","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00277-021-04568-y","article-title":"Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation","volume":"100","author":"A Wysocka-S\u0142owik","year":"2021","journal-title":"Ann Hematol"},{"key":"pone.0267092.ref007","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","article-title":"Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies","volume":"68","author":"LS Elting","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pone.0267092.ref008","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cncr.21622","article-title":"Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma","volume":"106","author":"M Vera-Llonch","year":"2006","journal-title":"Cancer"},{"key":"pone.0267092.ref009","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1254\/fpj.146.76","article-title":"A challenge to overcome stomatitis of cancer patients treated with chemotherapy (in Japanese)","volume":"146","author":"K Miyano","year":"2015","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"pone.0267092.ref010","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ijrobp.2016.08.047","article-title":"Salivary cytokine levels and oral mucositis in head and neck cancer patients treated with chemotherapy and radiation therapy","volume":"96","author":"P Bossi","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pone.0267092.ref011","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00520-019-04908-9","article-title":"Palliative care assessment of dry mouth: what matters most to patients with advanced disease?","volume":"28","author":"M Fleming","year":"2020","journal-title":"Support Care Cancer"},{"key":"pone.0267092.ref012","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.28592","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"RV Lalla","year":"2014","journal-title":"Cancer"},{"key":"pone.0267092.ref013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jpba.2017.03.037","article-title":"Metabolite quantification by NMR and LC-MS\/MS reveals differences between unstimulated, stimulated, and pure parotid saliva","volume":"140","author":"J Figueira","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"pone.0267092.ref014","first-page":"1767","article-title":"Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management","volume":"17","author":"JB Epstein","year":"2003","journal-title":"Oncology (Williston Park)"},{"key":"pone.0267092.ref015","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3390\/jcm10122631","article-title":"Time-course of salivary metabolomic profiles during radiation therapy for head and neck cancer","volume":"10","author":"W Yatsuoka","year":"2021","journal-title":"J Clin Med"},{"issue":"9","key":"pone.0267092.ref016","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/metabo11090587","article-title":"Salivary Metabolomics for Diagnosis and Monitoring Diseases: Challenges and Possibilities","volume":"11","author":"E Hyvarlnen","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"pone.0267092.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-020-01754-3","article-title":"Salivary metabolomics for the diagnosis of periodontal diseases: a systematic review with methodological quality assessment","volume":"17","author":"G Baima","year":"2021","journal-title":"Metabolomics"},{"key":"pone.0267092.ref018","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ajoms.2021.02.003","article-title":"Salivary metabolomics\u2013A diagnostic and biologic signature for oral cancer","volume":"33","author":"JP Deepa","year":"2021","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"pone.0267092.ref019","article-title":"Oral mucositis in head and neck cancer: risk, biology, and management","author":"ST Sonis","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"pone.0267092.ref020","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1016\/j.jprot.2012.05.018","article-title":"Detection and quantitation of forty eight cytokines, chemokines, growth factors and nine acute phase proteins in healthy human plasma, saliva and urine","volume":"75","author":"A Khan","year":"2012","journal-title":"J Proteomics"},{"key":"pone.0267092.ref021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2209\/tdcpublication.48.199","article-title":"Comparison of salivary cytokine levels in oral cancer patients and healthy subjects","volume":"48","author":"A Katakura","year":"2007","journal-title":"Bull Tokyo Dent Coll"},{"key":"pone.0267092.ref022","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00520-011-1116-x","article-title":"Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation","volume":"20","author":"H Kashiwazaki","year":"2012","journal-title":"Support Care Cancer"},{"key":"pone.0267092.ref023","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s00520-015-2774-x","article-title":"Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer","volume":"23","author":"K Kubota","year":"2015","journal-title":"Support Care Cancer"},{"key":"pone.0267092.ref024","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s00520-014-2282-4","article-title":"Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositis","volume":"22","author":"H Saito","year":"2014","journal-title":"Support Care Cancer"},{"key":"pone.0267092.ref025","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0885-3924(01)00318-9","article-title":"Xerostomia in patients with advanced cancer","volume":"22","author":"AN Davies","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"pone.0267092.ref026","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00520-014-2477-8","article-title":"Systematic literature review: xerostomia in advanced cancer patients","volume":"23","author":"S Hanchanale","year":"2015","journal-title":"Support Care Cancer"},{"key":"pone.0267092.ref027","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/1097-0142(19930901)72:5<1612::AID-CNCR2820720520>3.0.CO;2-Q","article-title":"A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients","volume":"72","author":"SB Woo","year":"1993","journal-title":"Cancer"},{"key":"pone.0267092.ref028","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02202.x","article-title":"Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue","volume":"110","author":"AM Wardley","year":"2000","journal-title":"Br J Haematol"},{"key":"pone.0267092.ref029","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1902\/jop.1972.43.1.38","article-title":"The plaque control record","volume":"43","author":"TJ O\u2019Leary","year":"1972","journal-title":"J Periodontol"},{"key":"pone.0267092.ref030","first-page":"388","article-title":"Periodontal and periimplant maintenance: a critical factor in long-term treatment success","volume":"30","author":"ND Shumaker","year":"2009","journal-title":"Compend Contin Educ Dent"},{"key":"pone.0267092.ref031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1348-8643(17)30017-4","article-title":"Evaluation of oral wetness using an improved moisture-checking device for the diagnosis of dry mouth","volume":"14","author":"Y Fukushima","year":"2017","journal-title":"Oral Sci Int"},{"key":"pone.0267092.ref032","doi-asserted-by":"crossref","first-page":"155506","DOI":"10.1016\/j.cyto.2021.155506","article-title":"Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: a systematic review","volume":"143","author":"T Diesch","year":"2021","journal-title":"Cytokine"},{"key":"pone.0267092.ref033","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s10103-017-2263-1","article-title":"Effect of photobiomodulation therapy on reducing the chemo-induced oral mucositis severity and on salivary levels of CXCL8\/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"32","author":"DRN Salvador","year":"2017","journal-title":"Lasers Med Sci"},{"key":"pone.0267092.ref034","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/biof.5520280103","article-title":"Salivary isoprostanes indicate increased oxidation injury in periodontitis with additional tobacco abuse","volume":"28","author":"RM Wolfram","year":"2006","journal-title":"Biofactors"},{"key":"pone.0267092.ref035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.freeradbiomed.2014.02.024","article-title":"Mass spectrometry-based metabolomic profiling identifies alterations in salivary redox status and fatty acid metabolism in response to inflammation and oxidative stress in periodontal disease","volume":"70","author":"Y Huang","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"pone.0267092.ref036","doi-asserted-by":"crossref","first-page":"120979","DOI":"10.1016\/j.talanta.2020.120979","article-title":"Saliva as a non-invasive tool for monitoring oxidative stress in swimmers athletes performing a VO(2max) cycle ergometer test","volume":"216","author":"D Biagini","year":"2020","journal-title":"Talanta"},{"key":"pone.0267092.ref037","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jpba.2018.11.043","article-title":"Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers","volume":"164","author":"C Pena-Bautista","year":"2019","journal-title":"J Pharm Biomed Anal"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0267092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T17:35:22Z","timestamp":1651080922000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0267092"}},"subtitle":[],"editor":[{"given":"Tommaso","family":"Lomonaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0267092","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]}}}